NEAL PHARMED

Business Nature: Manufacturer (Factory)

Company Profile:

Neal Pharmed is a prominent Iranian pharmaceutical company specializing in the research, development, and production of high-quality medicinal products. The company operates its own manufacturing facilities equipped with advanced technology to meet both domestic and international pharmaceutical standards. Their core focus lies in the formulation and production of generic medicines, specialized therapeutic agents, and healthcare solutions aimed at improving patient access to affordable and effective treatments. By maintaining rigorous quality control protocols and adhering to Good Manufacturing Practices (GMP), Neal Pharmed plays a vital role in the local healthcare infrastructure and the regional pharmaceutical market.

Neal Pharmed is an Iranian pharmaceutical company primarily focused on the production and distribution of specialized medications. Their product portfolio mainly includes the following categories:

Oncology and Hematology Medications

- Bortezomib (used for multiple myeloma and mantle cell lymphoma)

- Lenalidomide (used for multiple myeloma and myelodysplastic syndromes)

- Pemetrexed (used for mesothelioma and non-small cell lung cancer)

- Docetaxel (used for various cancers including breast, prostate, and lung)

- Paclitaxel (used for ovarian, breast, and lung cancer)

- Gemcitabine (used for pancreatic, lung, and bladder cancer)

- Oxaliplatin (used for colorectal cancer)

- Irinotecan (used for colorectal cancer)

Immunosuppressants and Others

- Cyclosporine (used to prevent organ rejection)

- Mycophenolate Mofetil (used to prevent organ rejection)

- Tacrolimus (used to prevent organ rejection)

- Various supportive care products for cancer patients

Please note that product availability and specific brand names may vary based on local market regulations and the company's current manufacturing cycles. For the most accurate and up-to-date list, it is recommended to consult the official Neal Pharmed product catalog or their regulatory filings.